| 06/01/2026 4:26 PM | Revelation Biosciences (1810560) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/15/2026 10:34 AM | ARMISTICE CAPITAL, LLC (1601086) Filed by Revelation Biosciences (1810560) Subject | Form SCHEDULE 13G | |
| 05/11/2026 8:56 AM | Revelation Biosciences (1810560) Filer | Form DEF 14A | |
| 05/11/2026 7:45 AM | Revelation Biosciences (1810560) Filer | Form ARS | |
| 05/07/2026 3:06 PM | Revelation Biosciences (1810560) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/01/2026 4:31 PM | Revelation Biosciences (1810560) Issuer Zygmont Chester Stanley III (1900657) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/01/2026 4:32 PM | Revelation Biosciences (1810560) Issuer Rolke James (1693858) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/30/2026 3:31 PM | Revelation Biosciences (1810560) Filer | Form PRE 14A | |
| 04/15/2026 3:13 PM | Revelation Biosciences (1810560) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 02/17/2026 8:37 PM | ARMISTICE CAPITAL, LLC (1601086) Filed by Revelation Biosciences (1810560) Subject | Form SCHEDULE 13G/A | |
| 02/17/2026 11:35 AM | Revelation Biosciences (1810560) Filer | Form DEF 14A | |
Get the Latest News and Ratings for REVBW and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Revelation Biosciences and its competitors with MarketBeat's FREE daily newsletter.
|
| 02/11/2026 11:15 PM | Revelation Biosciences (1810560) Filer | Form EFFECT | |
| 02/11/2026 4:30 PM | Revelation Biosciences (1810560) Filer | Form 424B3 | |
| 02/05/2026 4:29 PM | Revelation Biosciences (1810560) Issuer Zygmont Chester Stanley III (1900657) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/05/2026 4:29 PM | Revelation Biosciences (1810560) Issuer Rolke James (1693858) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/05/2026 4:30 PM | CARVER JENNIFER (1663163) Reporting Revelation Biosciences (1810560) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/05/2026 4:30 PM | Chawla Lakhmir S (1646626) Reporting Revelation Biosciences (1810560) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/05/2026 4:31 PM | Revelation Biosciences (1810560) Issuer ROPER JESS (1408993) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/20/2026 7:31 PM | Revelation Biosciences (1810560) Subject SABBY MANAGEMENT, LLC (1535610) Filed by | Form SCHEDULE 13G | |
| 01/12/2026 4:21 PM | Revelation Biosciences (1810560) Issuer Rolke James (1693858) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/12/2026 4:12 PM | CARVER JENNIFER (1663163) Reporting Revelation Biosciences (1810560) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/12/2026 4:17 PM | Revelation Biosciences (1810560) Issuer Zygmont Chester Stanley III (1900657) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/12/2026 4:08 PM | Revelation Biosciences (1810560) Issuer ROPER JESS (1408993) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/12/2026 4:01 PM | Chawla Lakhmir S (1646626) Reporting Revelation Biosciences (1810560) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/03/2025 4:01 PM | Revelation Biosciences (1810560) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/14/2025 5:15 PM | ARMISTICE CAPITAL, LLC (1601086) Filed by Revelation Biosciences (1810560) Subject | Form SCHEDULE 13G | |
| 11/12/2025 3:10 PM | Revelation Biosciences (1810560) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 11/10/2025 1:57 PM | Revelation Biosciences (1810560) Filer | Form DEF 14A | |
| 10/31/2025 11:54 AM | Revelation Biosciences (1810560) Issuer ROPER JESS (1408993) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/31/2025 11:55 AM | Revelation Biosciences (1810560) Issuer Zygmont Chester Stanley III (1900657) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/31/2025 11:56 AM | CARVER JENNIFER (1663163) Reporting Revelation Biosciences (1810560) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/31/2025 11:58 AM | Revelation Biosciences (1810560) Issuer Rolke James (1693858) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/31/2025 12:01 PM | Chawla Lakhmir S (1646626) Reporting Revelation Biosciences (1810560) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/31/2025 8:19 AM | Revelation Biosciences (1810560) Filer | Form PRE 14A | |
| 10/15/2025 4:06 PM | Revelation Biosciences (1810560) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/30/2025 11:15 PM | Revelation Biosciences (1810560) Filer | Form EFFECT | |
| 09/30/2025 4:13 PM | Revelation Biosciences (1810560) Filer | Form 424B3 | |
| 09/22/2025 3:15 PM | Revelation Biosciences (1810560) Filer | Form DEF 14A | |
| 09/16/2025 4:18 PM | Revelation Biosciences (1810560) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 09/15/2025 4:02 PM | Revelation Biosciences (1810560) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/12/2025 3:08 PM | Revelation Biosciences (1810560) Filer | Form PRE 14A | |
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (Ad) Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain. Get the name and ticker of Louis Navellier's #1 AI stock free |
| 09/09/2025 7:02 AM | Revelation Biosciences (1810560) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/08/2025 7:10 AM | Revelation Biosciences (1810560) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/25/2025 3:26 PM | Revelation Biosciences (1810560) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |